IPO Calendar
Lead Manager
- J P Morgan Chase (490)
- Goldman Sachs (463)
- Morgan Stanley (421)
- Bank of America Merrill Lynch (358)
- Citigroup (222)
- Jefferies (214)
- Credit Suisse (180)
- Barclays (151)
- Cowen and Company (147)
- Deutsche Bank (84)
- Leerink Partners (70)
- Piper Jaffray (70)
- Stifel (65)
- UBS Investment Bank (53)
- Evercore (52)
- RBC Capital (51)
- BMO Capital (49)
- Wells Fargo (47)
- Raymond James (38)
- William Blair (37)
More +
IPO - Pricing (70)
Piper Jaffray
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14 | Bellicum Pharma | Health-Care | 19 | 7 | CITI | JEFF | PPRJ | 129.4% | 25.7% | ||
| Oct 30 | Boot Barn Holdi | Consumer-Services | 16 | 5 | JPM | JEFF | PPRJ | 137.7% | 9.1% | ||
| Oct 29 | Sientra Inc. | Health-Care | 15 | 5 | PPRJ | Stifel | 75.2% | 11.7% | |||
| Oct 10 | Dave & Buster`s | Consumer-Services | 16 | 5 | JEFF | PPRJ | 119.8% | 7.7% | |||
| Jul 17 | CareDx Inc. | Health-Care | 10 | 4 | LRNK | PPRJ | 39.9% | -9.5% | |||
| Jun 25 | Amphastar Pharm | Health-Care | 7 | 8 | BMO | JEFF | PPRJ | 52% | 25% | ||
| Jun 25 | Materialise NV | Technology | 12 | 8 | CS | PPRJ | 75.9% | -3.7% | |||
| Feb 12 | Eagle Pharmaceu | Health-Care | 15 | 3 | PPRJ | WB | 177.3% | -14.5% | |||
| Feb 6 | Revance Therape | Health-Care | 16 | 6 | COWN | PPRJ | 84% | 67.8% | |||
| Jan 31 | Cara Therapeuti | Health-Care | 11 | 5 | PPRJ | Stifel | 40.3% | 17.4% | |||
| Nov 11 | Voyager Therape | Health-Care | 14 | 5 | COWN | PPRJ | 25.2% | 26.8% | |||
| Sep 17 | REGENXBIO Inc. | Health-Care | 22 | 6 | BAML | MS | PPRJ | 57.1% | 38.4% | ||
| Aug 5 | Zynerba Pharmac | Health-Care | 14 | 3 | JEFF | PPRJ | 51.2% | 16.1% | |||
| Jul 30 | vTv Therapeutic | Health-Care | 15 | 7 | PPRJ | Stifel | 64.2% | -27.4% | |||
| Jul 2 | Natera Inc. | Health-Care | 18 | 10 | COWN | MS | PPRJ | 136.6% | 26.3% | ||
| Jun 19 | Celyad SA | Health-Care | 68.6 | 1 | PPRJ | UBS | 61.2% | -20.4% | |||
| May 15 | Arcadia Bioscie | Basic-Industries | 8 | 8 | CS | JPM | PPRJ | 1% | 1725% | ||
| May 7 | Collegium Pharm | Health-Care | 12 | 5 | JEFF | PPRJ | 24.2% | 2.4% | |||
| Mar 25 | Cellectis S.A. | Health-Care | 41.5 | 5 | BAML | JEFF | PPRJ | 76.1% | -5.3% | ||
| Oct 19 | CRISPR Therapeu | Health-Care | 14 | 4 | BRCL | CITI | PPRJ | 47.1% | 0.6% | ||
| Sep 29 | Fulgent Genetic | Health-Care | 9 | 4 | CS | PPRJ | 57.4% | 2% | |||
| Sep 21 | Novan Inc. | Health-Care | 11 | 4 | PPRJ | 45.7% | 64.5% | ||||
| Jul 28 | Tactile Systems | Health-Care | 10 | 4 | CNCD | PPRJ | WB | 39.2% | 10.8% | ||
| Jul 21 | Impinj Inc. | Capital-Goods | 14 | 4 | PPRJ | RBC | 98.9% | 28.4% | |||
| Jun 30 | Syros Pharmaceu | Health-Care | 12.5 | 4 | COWN | PPRJ | 22% | 45.2% | |||
| Oct 13 | OptiNose Inc. | Health-Care | 16 | 7 | JEFF | PPRJ | BMO | 52.2% | 18.8% | ||
| Dec 10 | OrthoPediatrics | Health-Care | 13 | 4 | PPRJ | Stifel | 72.1% | 51.7% | |||
| Sep 28 | Deciphera Pharm | Health-Care | 17 | 7 | JPM | PPRJ | 77.2% | 3.8% | |||
| Apr 5 | Biohaven Pharma | Health-Care | 17 | 9 | MS | PPRJ | BRCL | 39.8% | 2.9% | ||
| Sep 27 | Ra Medical Syst | Health-Care | 17 | 3 | CNTR | PPRJ | 60.6% | 17.6% | |||
| Sep 27 | Sutro Biopharma | Health-Care | 15 | 5 | COWN | PPRJ | 47.7% | 1.3% | |||
| Sep 27 | Arvinas Inc. | Health-Care | 16 | 7 | CITI | GS | PPRJ | 45.6% | 0.3% | ||
| Jul 18 | Crinetics Pharm | Health-Care | 17 | 6 | JPM | LRNK | PPRJ | 60% | 44.2% | ||
| Jun 28 | Neuronetics Inc | Health-Care | 17 | 5 | PPRJ | WB | 45.5% | 63.4% | |||
| Jun 22 | electroCore Inc | Health-Care | 15 | 5 | EVCR | JMPS | PPRJ | 35.2% | 32.3% | ||
| May 4 | ASLAN Pharmaceu | Health-Care | 7 | 6 | LRNK | PPRJ | 13.6% | -20.2% | |||
| Feb 14 | Motus GI Holdin | Health-Care | 5 | 3 | OPPN | PPRJ | 18.6% | -12.4% | |||
| Nov 14 | Tandem Diabetes | Health-Care | 15 | 8 | BAML | PPRJ | 5% | 1184% | |||
| Oct 18 | voxeljet AG | Capital-Goods | 13 | 6 | CITI | PPRJ | 189.4% | 121.5% | |||
| Sep 26 | Applied Optoele | Technology | 10 | 3 | PPRJ | RAYJ | 26.4% | -0.4% | |||
| Aug 8 | Fox Factory Hol | Consumer-Non-Durables | 15 | 8 | PPRJ | RWB | WB | 74.3% | 24.1% | ||
| Aug 2 | Marrone Bio Inn | Basic-Industries | 12 | 4 | JEFF | PPRJ | 20.7% | 14.6% | |||
| Aug 3 | Globus Medical | Health-Care | 12 | 8 | BAML | GS | PPRJ | 46.8% | 12.5% | ||
| Jul 25 | Natural Grocers | Consumer-Services | 15 | 7 | PPRJ | SNTR | 88% | 19.1% | |||
| May 4 | Tilly s Inc | NA | 15.5 | 8 | BAML | GS | PPRJ | 115.2% | 8.5% | ||
| May 1 | Supernus Pharma | Health-Care | 5 | 10 | CITI | PPRJ | 6.8% | 7.4% | |||
| Feb 24 | Proto Labs Inc | Capital-Goods | 16 | 4 | JEFF | PPRJ | 94% | 81.3% | |||
| Jul 21 | Turnstone Biolo | Health Care | 12 | 6 | BAML | LRNK | PPRJ | 17.2% | -8.3% | ||
| May 9 | NextCure Inc. | NA | 15 | 5 | MS | BAML | PPRJ | 32.9% | 32.7% | ||
| May 9 | Milestone Pharm | NA | 15 | 5 | JEFF | COWN | PPRJ | 17.9% | 2.5% | ||
| May 23 | Bicycle Therape | NA | 14 | 4 | GS | JEFF | PPRJ | 22.8% | -14.3% | ||
| Sep 18 | IGM Biosciences | Health-Care | 16 | 10 | JEFF | PPRJ | Stifel | 16% | 51.9% | ||
| Oct 31 | Oyster Point Ph | Health-Care | 16 | 5 | JPM | COWN | PPRJ | 20.4% | 17.4% | ||
| Nov 8 | TELA Bio Inc. | Health-Care | 13 | 4 | JEFF | PPRJ | 31.8% | 2.7% | |||
| Jul 24 | Inozyme Pharma | Health-Care | 17 | 14 | BAML | COWN | PPRJ | 11.8% | 3.2% | ||
| Aug 19 | Harmony Bioscie | Health-Care | 37 | 24 | GS | JEFF | PPRJ | 2.4% | -2.5% | ||
| Oct 2 | Oncorus Inc. | Health-Care | 15 | 5 | JEFF | EVCR | PPRJ | 12.6% | 6.7% | ||
| Oct 8 | Aziyo Biologics | Health-Care | 17 | 2 | PPRJ | COWN | 70.5% | -14.7% | |||
| Oct 16 | Aligos Therapeu | Health-Care | 15 | 10 | JPM | JEFF | PPRJ | 27.6% | -1% | ||
| Dec 3 | Kinnate BioPhar | Health-Care | 20 | 12 | GS | LRNK | PPRJ | 5.3% | 117.3% | ||
| Feb 4 | Sensei Biothera | Health-Care | 19 | 7 | CITI | PPRJ | OPPN | 52.7% | -0.5% | ||
| Feb 12 | Talis Biomedica | Health-Care | 16 | 13 | JPM | BAML | PPRJ | 22.8% | 73.8% | ||
| Mar 4 | Khosla Ventures | Finance | 10 | 30 | GS | PPRJ | 28.1% | 2.5% | |||
| Mar 19 | Connect Biophar | Health-Care | 17 | 11 | JEFF | PPRJ | CICC | 28.4% | 8.8% | ||
| Jul 23 | Cytek BioScienc | Health-Care | 17 | 16 | MS | GS | PPRJ | 18.9% | 10.4% | ||
| Jul 29 | Nuvalent Inc. | Health-Care | 17 | 9 | JPM | COWN | PPRJ | 23.9% | 10.3% | ||
| Oct 15 | Paragon 28 Inc. | Health-Care | 16 | 7 | BAML | PPRJ | 55.7% | 13.6% | |||
| Oct 20 | Ventyx Bioscien | Health-Care | 16 | 9 | JEFF | EVCR | PPRJ | 17.9% | 31.4% | ||
| Feb 4 | Silver Spike In | Finance | 14 | 6 | Stifel | PPRJ | 4.3% | 0% | |||
| May 11 | Hanover Bancorp | Finance | 21 | 1 | STPH | PPRJ | 31.6% | 0.5% | |||
*
Lead manager or one of top three managers in an underwriting team.